Date published: 2026-5-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

ARRDC5 Inhibitors

ARRDC5 inhibitors are a class of small molecules or compounds that specifically target and inhibit the activity of the Arrestin Domain-Containing Protein 5 (ARRDC5). ARRDC5 belongs to the family of arrestin proteins, which are known for their involvement in regulating G protein-coupled receptors (GPCRs) and other cellular processes. This particular protein is part of a subgroup called α-arrestins, which are associated with endocytosis and trafficking of membrane proteins. Inhibition of ARRDC5 alters these pathways by preventing the recruitment of key cellular machinery involved in internalizing and recycling surface proteins. This can have significant effects on intracellular signaling networks and overall cell homeostasis, as ARRDC5 plays a critical role in regulating protein sorting and degradation.

The chemical inhibitors of ARRDC5 are designed to interfere with the protein's ability to interact with specific molecular partners, such as ubiquitin ligases or GPCRs. By blocking these interactions, ARRDC5 inhibitors can modulate cellular signaling pathways, including those involved in protein ubiquitination and degradation processes. Furthermore, the inhibition of ARRDC5 can lead to changes in membrane protein turnover and trafficking, potentially impacting cell surface receptor levels and other proteins vital to cellular communication and function. Structural studies of ARRDC5 and its inhibitors often focus on identifying binding sites and the precise molecular mechanisms by which inhibition is achieved, providing insights into how these inhibitors exert their effects at the biochemical level.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Exo1

461681-88-9sc-200752
sc-200752A
10 mg
50 mg
$84.00
$297.00
4
(1)

Exo1 inhibits the exosome complex, which is involved in mRNA degradation, including mRNAs that encode arrestin domain containing 5, reducing its production.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Lactacystin inhibits the proteasome, which could lead to increased degradation of misfolded arrestin domain containing 5 proteins before they become functional.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Bafilomycin A1 inhibits the vacuolar H+-ATPase (V-ATPase), potentially leading to lysosomal dysfunction and subsequent degradation of arrestin domain containing 5.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132 inhibits the proteasome, potentially increasing the degradation of misfolded or damaged arrestin domain containing 5 proteins.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine inhibits lysosomal acidification, which can disrupt the lysosomal degradation pathway, potentially leading to the accumulation of defective arrestin domain containing 5.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$281.00
$947.00
$1574.00
14
(0)

E-64 inhibits cysteine proteases, which may lead to an accumulation of defective arrestin domain containing 5 proteins by preventing their degradation.

Leupeptin hemisulfate

103476-89-7sc-295358
sc-295358A
sc-295358D
sc-295358E
sc-295358B
sc-295358C
5 mg
25 mg
50 mg
100 mg
500 mg
10 mg
$73.00
$148.00
$316.00
$499.00
$1427.00
$101.00
19
(3)

Leupeptin inhibits lysosomal proteases, which could lead to an accumulation of non-functional arrestin domain containing 5 proteins due to impaired degradation.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Monensin disrupts Golgi function, which can lead to improper glycosylation and misfolding of arrestin domain containing 5, resulting in its functional inhibition.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$166.00
$322.00
436
(1)

Puromycin causes premature chain termination during protein synthesis, leading to the production of truncated, non-functional arrestin domain containing 5 proteins.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits eukaryotic protein synthesis, leading to a decrease in overall protein levels, including potentially non-functional arrestin domain containing 5.